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Abstract: A 61-year-old, nontransfused, Caucasian male was 
found to have a positive direct antiglobulin test (DAT) and an auto- 
antibody in his serum prior to total hip replacement. Autoabsorption 
with the patient's ZZAP-treated red cells failed to absorb the auto- 
antibody, giving a clue to its possible specificity, which was subse- 
quently found to be Kell-system related. In addition, his red cells 
were found to have a slightly weakened expression of Kell system 
antigens. The patient was fit and healthy with normal hematological 
indices at the time of the operation. One year the hemlogical 
findings remained the same despite the persistence of the auto- 
antibody and a positive DAT. This suggested that the autoantibody 
was benign, which was supported by a negative in vitro mactophage 
assay. 
In some cases of warm autoimmune hemolytic 
anemia with autoantibody in the serum, it is useful to 
perform autoabsorption tests to detect any underlying 
alloantibodies. An effective reagent for the removal of 
autoantibody, allowing the cells to be used for subse- 
quent autoabsorption procedures, is ZZAPsup(1-4) [a mixture 
of papain and dithiothreitol (DTT)]. ZZAP treatment 
of red cells destroys certain erythrocyte antigens (in- 
cluding M, N, S, s, Fy sup(a), Fy sup(b), LWsup(a), LWsup(b), Ytsup(a)), and those 
of the Kell blood group system, and this can be a 
drawback.sup(5) However, this property can be used as an 
indicator of the possible specificity of an unabsorbed 
autoantibody, as we will demonstrate. The serum was 
subsequently tested against cells lacking selected high- 
incidence antigens, including & cells. Only Ksub(o) cells 
were compatible, suggesting that the autoantibody had 
a Kell-related specificity. 
Case Report  
Serum from a 61-year-old, nontransfused, Caucasian 
male was tested for antitodies prior to a total hip replace- 
ment. The patient's serum contained an IgG1 auto- 
antibody that reacted with all reagent red cells by a 
two-stage papain test and the LISS antihuman globulin 
(AHG) test. His DAT was positive with polyspefic AHG 
and monospecific anti-IgG and -IgG(Fc) AHG reagents. 
The patient showed no signs of hemolysis, and his hema- 
tological indices were within normal limits. The only 
previous illnesses of note were a severe bout of 
pneumonia 25 years before, which was treated with 
chloromycetin, and malaria during his army service. 
Materials and Methods  
Adsorptions of the patient's serum were performed 
twice, in sequence, using autologous red cells treated 
with ZZAP (in-house preparation following the method 
of Branch and Petz). Eluates were prepared from the 
patient's red cells, Kp(a+b-), Ksub(0), and KL-negative 
(McLeod phenotype) red cells that had been previously 
incubated with the patient's serum using Rubens ether, 
Elukit II (Gamma Biologicals, Houston, TX), or EDTA/ 
HClsup(6) techniques. Netherlands Red Cross IgG subclass 
typing reagents were obtained from Janssen Pharma- 
ceutical, Wantage, Oxon. Mononuclear phagocyte assays 
(MPA) were performed following the method of Hunt 
et al.,sup(7) as modified by Herron et al.sup(8) 
Serum and eluate testing 
Unabsorbed serum, autoabsorbed serum, and the 
eluates were tested using a standard LISS spin AHG test 
and papain-treated reagent panel cells (all prepared in 
house). Reagent red cells were from fresh ACD samples 
(in house), and the rare cells were gifts from the United 
States (via SCARF) and United Kingdom red cell ex- 
change programs and stored in liquid nitrogen or 
glycerol citrate until used. 
Red cell phenotyping 
Autologous red cells were treated with chloroquine 
diphosphate (CDP) sup(9) (Sterling Organics Ltd, North- 
umberland, UK) to remove the bound autoantibody and 
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tested with reagents prepared in house. Anti-IgG AHG 
was prepared in house or obtained from the Blood Pro- 
ducts Iaboratory (Diagnostics), Oxford, UK. Agglutina- 
tion reactions were scored according to Marsh. 10 
Results 
The patient's red cells had a weakly positive DAT with 
polyspecific anti-IgG and anti-IgG(Fc) AHG reagents. 
Phenotyping results performed on CDP-treated (DAT- 
negative) red cells were as follows: Group O, 
D+C+c+E-e+;  M+N+S-s+; Psub(1), +;  Lu(a-h+); 
Le(a-b+); FHa-h+);Jk(a+h+); En(a+); Ge:2,3; Kn(a+); 
P + ;  U + ;  Jk:3; Gy(a+); Vel+; Co(a+); Er(a+); Yt(a+); 
Sc:1 and LW(a+). His red cells possessed the most com- 
mon Kell phenotype: K-k+; Kp(a-b+); Js(a-b+); 
Ku+; K:11,-l7. Slight depression of k, Kp sup(b), Js sup(b), and 
Ku antigens, compared to the Kp(a-b+) control cells, 
was apparent on titration studies (Table 1). 
The patient's unabsorbed and autoabsorbed serum 
reacted strongly by a two-stage papain technique and 
the LISS AHG test with all reagent panel cells and cells 
with the following rare phenotypes: S - s - U - ; 
Lu(a-h-); P-(pp); Luke-; Jr(a-); Co(a-); Fy(a-b-); 
Rh sub(null); -D-; I - i+;  Vel-; M-N-S-s- (Msup(k)Msup(k)); 
Jk(a-b-); Sc:-1; Ge:1,-2,-3; Er(a-), Yt(a-). The 
following cells were compatible: Ksub(o), 'Ksub(o)' (ZZAP- 
treated), and KL-negative (McLeod phenotype) cells. 
Kp(a+h-) cells reacted more weakly than cells with 
'normal' Kell phenotypes, as did the patient's own cells 
(Table 2). In addition, cells with the following rare Kell 
phenotypes were strongly incompatible with the pa- 
tient's unabsorbed serum: K: - 11,17, K: - 14, K: - 19, 
K: - 22. Red cells lacking other high-frequency, Kell- 
related antigens were not available for testing. 
Table 2 
Results of testing the patient's serum against Ed cells of various Kell 
phenotypes 
Patient's serum 
Red Cells Titer SCORE 
Patient 





KK Kp(a-b+) Jb(a-b+) 64 61 
kk Kp(a-b+) Js(a+b-) 32 45 
kk Kp(a+b-)Js(a-h+) 4 17 
kk Kp(a+b+ ) Js(a- b +) 64 59 
KL-negative (McLeod) 0 0 
Ksub(o) 0 0 
The Kell system-related autoantibody was shown to 
be IgG1. 
Eluates prepared from Kp(a+ b-), KL-negative, and 
Ksub(o) cells after adsorption with the patient's serum, and 
an eluate from the patient's own cells were tested with 
red cells of varying Kell system phenotypes. Results are 
shown in Table 3 .  Although KL-negative cells did not 
Table 3 
Results of testing eluates 
Eluates from 
Cells Auto Kp(a+b-) KL-negative Ksub(o) 
kk Kp(a-b+) + + + + + + + + + +  + + +  - 
KK Kp(a-b+) NT * + + + + +  + + +  - 
kk Kp(a+h-) + + +  + + + +  - - 
KLnegative - NT - - 
Ksub(o) - - - - + + NT NT Patient 
*Not tested 
Table 1 
Results of titration studies against Kell antibodies 
Anti-k Anti-Kp sup(b) Anti-Js sup(h) Anti-Ku(Cav) Anti-Ku(Cor) Anti-KL 
Red Cells Titer Score Titer Score Titer Score Titer Score Titer Score Titer Score 
Patient 
Kp(a-b+),K-k- 
-- + 8 13 16 26 8 14 > 128 48 > 128 33 16 25 
Control 
Kp(a-h+),K-k- 
-- I6 34 32 36 32 42 > 128 72 > 128 76 16 27 
Kp(a+b-)* 4 15 0 0 8 26 > 128 55 > 128 56 16 26 
KL-negative 
(McLeod) 1 1 2 5 4 8 NTt NT 0 0 
Ksub(o) 0 0 0 0 0 0 0  0  0  0  I6 30 
*It is known that Kp(a+h-) cells can have depressed Kell system antigens" 
†Not tested 
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react directly with either the patient’s serum or the eluate 
from his cells, they were capable of adsorbing and 
eluting the antibody and were, as such, considered to 
be weakly positive for the autoantibody specificity. 
The results of the MPA using the patient’s own DAT- 
positive red cells that had been previously incubated 
in vitro with his serum were negative, using four 
allogeneic macrophage donors. We were not able to 
perform the MPA using autologous macrophages. 
Discussion 
Autoantibodies with Kell-related specificities are un- 
common; they are often associated with depression of 
the patient’s Kell system antigens and sometimes with 
the presence of alloanti-K1. sup(11) The patient in this study 
had a moderate depression of Kell antigens, but anti- 
K1 was not detected in the serum. The antibody showed 
preference for Kp(b+) cells. Kp(a+b-) cells, which were 
less strongly reactive, are known to give weaker reactions 
with Kell system antibodies when compared with cells 
of a common Kell type.sup(12) KL-negative cells have a more 
markedly reduced expression of Kell antigens sup(13) and 
were positive with the patient’s antibody by absorption/ 
elution techniques only. The only nonreactive cells were 
those of the phenotype, which lack all antigens pro- 
duced by the Kell gene, and the autoantibody may, 
therefore, have Ku (K5) specificity.sup(14) 
The inability of the ZZAP-treated patient’s cells to 
absorb the antibody suggested that the antibody could 
be directed towad a ZZAP-sensitive antigen, for example, 
M, N, S, s, Fy sup(a), Fy sup(b), LWsup(a), LWsup(b), Yt sup(a), or Kell system anti- 
gens. Despite the comment of Gorman and Gladden5 
that “technologists rarely consider antigen denaturation 
by DTT when using ZZAP to treat red cells for auto- 
adsorption,” the knowledge that ZZAP destroys various 
red cell antigens was a prime consideration when we 
found that the autoantibody had not been absorbed. 
Whenever serologists treat red cells with any chemical 
or enzyme, the various effects of the treatment should 
always be a primary consideration when interpreting 
the results of subsequent antibody tests. However, even 
if the deleterious effects of ZZAP on certain red cell 
antigens had not been considered and the conclusion 
drawn that the antibody left after autoabsorption was 
an alloantibody, tests against cells lacking high-incidence 
antigens would have been performed. The autoreactive 
nature of the antibody would then have heen confirmed 
during subsequent typing of the patient’s red cells. 
The immunogen for this antibody is unknown. There 
have been several reports of bacterial infections inducing 
‘K’ -like antibodies and certain bacteria, and their 
products have been shown to neutralize anti-K1.sup(15) The 
patient has been and remains fit and healthy. His 
hematological indices were normal at the time be was 
admitted for surgery and the antibody was detected. 
To date (one year later), they remain normal and the 
serum antibody, eluted antibody, and DAT strength re- 
main unchanged. 
The depression of Kell antigens in patients with Kell- 
related autoimmunity may protect them to a certain ex 
tent from the full hemolytic effects of their autoantibody. 
A severe hemolytic reaction has been reported in a pa- 
tient with depressed Kp sup(b) antigens and autoanti-Kpb 
after transfusion of Kp(b+) blood.sup(16) Although normal 
results obtained with the MPA implied that our patient’s 
IgGl autoantibody was unlikely to be clinically signifi- 
cant, it was decided to use autologous blood to cover 
his elective surgical procedure. Four units of autologous 
blood were subsequently collected by ‘leap frog’ tech- 
nique, and the patient had a successful hip replacement 
and autologous blood transfusion with no untoward 
effects. 
Acknowledgments 
Our thanks to Mrs. Anne Price for her secretarial 
assistance in typing this manuscript and to Jackie Banks 
for technical assistance. 
References 
1. Branch DR. Petz LD. A new reagent (ZZAP) having multiple 
applications in immunohematology. Am J Clin Pathol 
1982:78:161-7. 
2. Wallhermfechtel MA, Pohl BA, Chaplin H. AUoimmunization 
in patients with warm autoantibodies. Transfusion 
1984;24:482-5. 
3. Laine ML, Beattie KM. Frequency of alloantibodies accompanying 
autoantibodies. Transfusion 1985;25:545-6. 
4. James P, Rowe GP: Tozzow GG. Elucidation of alloantibodies in 
autoimmune hemolytic anemia. Vox Sang 1988;54:167-71. 
5 .  Gorman M, Gladden J. A case report: use of ZZAP reagents in 
the investigation of warm autoimmune hemolytic anemia. 
Immunohematology 1988;4(2)38-40. 
6. Louie JE, Jiang M, Zaroulis CG. Preparation of intact antibody-free 
red blood cells in autoimmune hemolytic anemia (abstract). 
Transfusion 1986;26:550. 
7. Hunt JS, Beck ML, Wood GM. Monocyte mediated erythrocyte 
destruction. A comparative study of current methods. Transfusion 
1981;21:735-8. 
8. Herron R, Clark M, Young D, Smith DS. Cumlation of 
mononuclear phagocyte assay results and in vivo hemolytic 
rate in subjects with a positive direct antiglobulin test. Clin Lab 
Haematol 1986;8:199-207. 
9. Edwards JM, Moulds JJ, Judd WJ. Chloroquine dissociation of 
V O L U M E  5, N U M B E R  3, 1 9 8 9  81 
G.P. ROWE ET AL. 
antigen-antibody complexes. A new technique for typing red 
blood cells with a positive direct antiglobulin test. Transfusion 
1982;22:59-61. 
10. Marsh WL. Scoring of hemagglutination reaction?. Transfusion 
1972;12:352-3. 
11. Marsh WL, Oyen R, Alicea E, Linter M, Horton S .  Autoimmune 
hemolytic anemia and the Kell blood groups. Am J Hematol 
1979;7:155-62. 
12. Marsh WL, Redman CM. Recent developments in the Kell blood 
group system. Trans Med Rw 1978;1:4-20. 
13. Allen FN, Krabble S M R ,  Corcoran PA. A new phenotype (McLeod) 
in the Kell blood group system. Vox Sang 1961;6:555-60. 
14. Corcoran PA, Men FH, Jr, Lewis M, Chown B. A new antibody 
anti-Ku (anti-Peltz) in the Kell blood p u p  system. Transfusion 
1961;1:181-3. 
15. Savalonis JM, Kalish RI, Cummings EA, Ryan RW, Aloisi R. Kell 
blood p u p  activity of gram-negative bacteria. Tranfusion 
1988;28:229-32. 
16. Seyfried H, Gorska B, Maj S ,  Sylvestrowicz T, Giles CM, Goldsmith 
KL. Apparent depression of antigens of the Kell blood group 
system associated with autoimmune acquired hemolytic anemia. 
vox Sang 1972;23:528-36. 
Mr. Graham P. Rowe, FIMLS, Head of Reference 
Serology, Welsh Regional Blood Transfusion Service, 
Rhydlafar; Cardiff; Wales, CF5 6XF; Mr. Guiseppe 
G. Tozzo, FIMLS, Rhydlafar; Cardiff, Wales; Ms. 
Joyce Poole, FIMLS, Oxford England; Mr. Yew Wah 
Liew, BSc, Oxford, England. 
82 I M M U N O H E M A T O L O G Y  
